Skip to main content

Advertisement

Log in

ENT Wegener’s granulomatosis can hide severe central nervous system involvement

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The clinical manifestations of localised or early systemic forms of Wegener’s granulomatosis (WG) do not require immediate treatment to save the patient’s life and/or the function of a vital organ. The organs mainly involved are the ear, nose, throat (ENT) and lung, and the results of antineutrophil cytoplasmic antibody (ANCA) assays are frequently negative. We here describe three cases of the ANCA-negative early systemic form of WG with prevalent ENT involvement complicated by severe central nervous system (CNS) disease; in two cases, the only symptom was a mild headache. We conclude that, although apparently mild, the localised and early systemic forms of WG can hide CNS involvement and may require immediate treatment. This complication should be suspected and investigated in the case of patients with localised or early systemic disease especially in the presence of ENT involvement and negative ANCA assays.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jayne D (2001) Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13:48–55

    Article  CAS  PubMed  Google Scholar 

  2. Lamprecht P, Gross WL (2004) A brief history of Wegener’s granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by WGET. Arthritis Rheum 50:334–335

    Article  PubMed  Google Scholar 

  3. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR (1995) The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 123:925–32

    CAS  PubMed  Google Scholar 

  4. Drachman DA (1963) Neurological complication of Wegener’s granulomatosis. Arch Neurol 8:145–155

    Google Scholar 

  5. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo clinic. Ann Neurol 33:4–9

    CAS  PubMed  Google Scholar 

  6. Reinhold-Keller E, de Groot K, Holl-Ulrich K, Arlt AC, Heller M, Feller AC, Gross WL (2001) Severe CNS manifestation as the clinical hallmark in generalized Wegener’s granulomatosis consistently negative for antineutrophil antibodies. A report of 3 cases and a review of the literature. Clin Exp Rheumatol 19:541–549

    CAS  PubMed  Google Scholar 

  7. Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107

    CAS  PubMed  Google Scholar 

  8. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192

    CAS  PubMed  Google Scholar 

  9. Murphy JM, Gomez-Anson B, Gillard JH, Antoun NM, Cross J, Elliott JD, Lockwood M (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213:794–799

    CAS  PubMed  Google Scholar 

  10. Stone JH, Wegener’s Granulomatosis Etanercept Trial Research Group (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis eternacept trial. Arthritis Rheum 48:2299–2309

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Tumiati.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tumiati, B., Zuccoli, G., Pavone, L. et al. ENT Wegener’s granulomatosis can hide severe central nervous system involvement. Clin Rheumatol 24, 290–293 (2005). https://doi.org/10.1007/s10067-004-1025-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1025-1

Keywords

Navigation